This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Myasthenia Gravis
and you are
between 18 and 70
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

To evaluate the efficacy and safety of tacrolimus capsules in patients with myasthenia gravis who are inadequately treated by glucocorticoid.

Provided treatments

  • Drug: Tacrolimus capsule
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01325571. The sponsor of the trial is Astellas Pharma Inc and it is looking for 83 volunteers for the current phase.
Official trial title:
A Randomized, Double-blinded, Placebo-controlled, and Multi-centered Clinical Trial Evaluating the Efficacy and Safety of Tacrolimus Capsule in Myasthenia Gravis That Was Insufficiently Treated by Glucocorticoid Therapy